{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:39:00Z","timestamp":1788979140539,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hilkka Kauhanen Memorial Fund"},{"name":"Grant EVO of Satakunta Hospital District"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12877-018-0829-9","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:16:48Z","timestamp":1529021808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4033-1539","authenticated-orcid":false,"given":"Juha","family":"Puustinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"L\u00e4hteenm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Nurminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Vahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertti","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Partinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismo","family":"R\u00e4ih\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertti J.","family":"Neuvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka-Liisa","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"issue":"2","key":"829_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/thoraxjnl-2012-202374","volume":"68","author":"E Obiora","year":"2013","unstructured":"Obiora E, Hubbard R, Sanders RD, Myles PR. The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax. 2013;68(2):163\u201370.","journal-title":"Thorax"},{"issue":"5","key":"829_CR2","doi-asserted-by":"publisher","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","volume":"10","author":"G Zhong","year":"2015","unstructured":"Zhong G, Wang Y, Zhang Y, Zhao Y. Association between benzodiazepine use and dementia: a meta-analysis. PLoS One. 2015;10(5):e0127836.","journal-title":"PLoS One"},{"issue":"12","key":"829_CR3","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00228-015-1955-3","volume":"71","author":"H Park","year":"2015","unstructured":"Park H, Satoh H, Miki A, Urushihara H, Sawada Y. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429\u201340.","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"829_CR4","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2015","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert P. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227\u201346.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"829_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, Tahkapaa S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J. Long-term use of benzodiazepines: definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry. 2015;30(8):1037\u201347.","journal-title":"Eur Psychiatry"},{"issue":"12","key":"829_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2165\/00002512-200724120-00007","volume":"24","author":"J Puustinen","year":"2007","unstructured":"Puustinen J, Nurminen J, Kukola M, Vahlberg T, Laine K, Kivela SL. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly. Drugs Aging. 2007;24(12):1045\u201359.","journal-title":"Drugs Aging"},{"issue":"17","key":"829_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12875-016-0469-0","volume":"6","author":"K Linnet","year":"2016","unstructured":"Linnet K, Gudmundsson LS, Birgisdottir FG, Sigurdsson EL, Johannsson M, Tomasdottir MO, Sigurdsson JA. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland. BMC Fam Pract. 2016;6(17):69. \n                    https:\/\/doi.org\/10.1186\/s12875-016-0469-0.","journal-title":"BMC Fam Pract"},{"issue":"9","key":"829_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2165\/00002512-200522090-00008","volume":"22","author":"H Hosia-Randell","year":"2005","unstructured":"Hosia-Randell H, Pitk\u00e4l\u00e4 K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging. 2005;22(9):793\u2013800.","journal-title":"Drugs Aging"},{"issue":"7","key":"829_CR9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.sleep.2013.03.012","volume":"14","author":"J Bourgeois","year":"2013","unstructured":"Bourgeois J, Elseviers MM, Van Bortel L, Petrovic M, Vander Stichele RH. Sleep quality of benzodiazepine users in nursing homes: a comparative study with nonusers. Sleep Med. 2013;14(7):614\u201321. \n                    https:\/\/doi.org\/10.1016\/j.sleep.2013.03.012\n                    \n                  .","journal-title":"Sleep Med"},{"issue":"7","key":"829_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1517\/14740338.2014.925444","volume":"13","author":"AM Paquin","year":"2014","unstructured":"Paquin AM, Zimmerman K, Rudolph JL. Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf. 2014;13(7):919\u201334.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"829_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1192\/bjp.bp.113.126003","volume":"204","author":"RL Gould","year":"2014","unstructured":"Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204(2):98\u2013107.","journal-title":"Br J Psychiatry"},{"issue":"7","key":"829_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1017\/S0033291703008213","volume":"33","author":"HV Curran","year":"2003","unstructured":"Curran HV, Collins R, Fletcher S, Kee SC, Woods B, Iliffe S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003;33(7):1223\u201337.","journal-title":"Psychol Med"},{"issue":"5","key":"829_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/10673229709030554","volume":"4","author":"C Salzman","year":"1997","unstructured":"Salzman C. The benzodiazepine controversy: therapeutic effects versus dependence, withdrawal, and toxicity. Harv Rev Psychiatry. 1997;4(5):279\u201382.","journal-title":"Harv Rev Psychiatry"},{"issue":"1","key":"829_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brat.2003.12.002","volume":"43","author":"CM Morin","year":"2005","unstructured":"Morin CM, Belanger L, Bastien C, Vallieres A. Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behav Res Ther. 2005;43(1):1\u201314.","journal-title":"Behav Res Ther"},{"issue":"643","key":"829_CR15","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.3399\/bjgp16X683485","volume":"66","author":"C Vicens","year":"2016","unstructured":"Vicens C, Sempere E, Bejarano F, Socias I, Mateu C, Fiol F, Palop V, Mengual M, Folch S, Lera G, Basora J, Leiva A. Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care. Br J Gen Pract. 2016;66(643):e85\u201391. \n                    https:\/\/doi.org\/10.3399\/bjgp16X683485\n                    \n                  .","journal-title":"Br J Gen Pract"},{"issue":"6","key":"829_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/bcp.12294","volume":"77","author":"R Lahteenmaki","year":"2014","unstructured":"Lahteenmaki R, Puustinen J, Vahlberg T, Lyles A, Neuvonen PJ, Partinen M, Raiha I, Kivela SL. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial. Br J Clin Pharmacol. 2014;77(6):975\u201385.","journal-title":"Br J Clin Pharmacol"},{"key":"829_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2318-14-121","volume":"14","author":"J Nurminen","year":"2014","unstructured":"Nurminen J, Puustinen J, Lahteenmaki R, Vahlberg T, Lyles A, Partinen M, Raiha I, Neuvonen PJ, Kivela SL. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics. BMC Geriatr. 2014;14:121.","journal-title":"BMC Geriatr"},{"issue":"3","key":"829_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-013-1613-6","volume":"70","author":"J Puustinen","year":"2014","unstructured":"Puustinen J, Lahteenmaki R, Polo-Kantola P, Salo P, Vahlberg T, Lyles A, Neuvonen PJ, Partinen M, Raiha I, Kivela SL. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults. Eur J Clin Pharmacol. 2014;70(3):319\u201329.","journal-title":"Eur J Clin Pharmacol"},{"key":"829_CR19","volume-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"1994","unstructured":"APA. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.","edition":"4"},{"issue":"10","key":"829_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8","volume":"14","author":"OP Almeida","year":"1999","unstructured":"Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry. 1999;14(10):858\u201365.","journal-title":"Int J Geriatr Psychiatry"},{"key":"829_CR21","volume-title":"Classification of Medicines (ATC) and Defined Daily Doses (DDD)","author":"National Agency of Medicines","year":"1996","unstructured":"National Agency of Medicines. Classification of Medicines (ATC) and Defined Daily Doses (DDD). Helsinki: National Agency for Medicines; 1996."},{"key":"829_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2318-11-70","volume":"11","author":"J Puustinen","year":"2011","unstructured":"Puustinen J, Nurminen J, Lopponen M, Vahlberg T, Isoaho R, Raiha I, Kivela SL. Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study. BMC Geriatr. 2011;11:70.","journal-title":"BMC Geriatr"},{"issue":"2","key":"829_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","volume":"77","author":"M Lader","year":"2014","unstructured":"Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014;77(2):295\u2013301.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"829_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890\u20138. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2014.949\n                    \n                  .","journal-title":"JAMA Intern Med"},{"key":"829_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.brat.2013.09.006","volume":"51","author":"KL Lichstein","year":"2013","unstructured":"Lichstein KL, Nau SD, Wilson NM, Aguillard RN, Lester KW, Bush AJ, McCrae CS. Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample. Behav Res Ther. 2013;51:78\u201396.","journal-title":"Behav Res Ther"},{"issue":"345","key":"829_CR26","doi-asserted-by":"publisher","first-page":"e8343","DOI":"10.1136\/bmj.e8343","volume":"17","author":"TB Huedo-Medina","year":"2012","unstructured":"Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ. 2012;17(345):e8343. \n                    https:\/\/doi.org\/10.1136\/bmj.e8343\n                    \n                  .","journal-title":"BMJ"},{"issue":"12","key":"829_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s40266-015-0322-5","volume":"32","author":"A Wright","year":"2015","unstructured":"Wright A, Diebold J, Otal J, Stoneman C, Wong J, Wallace C, Duffett M. The effect of melatonin on benzodiazepine discontinuation and sleep quality in adults attempting to discontinue benzodiazepines: a systematic review and meta-analysis. Drugs Aging. 2015;32(12):1009\u201318.","journal-title":"Drugs Aging"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-018-0829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12877-018-0829-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-018-0829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T19:11:03Z","timestamp":1560539463000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-018-0829-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1186\/s12877-018-0829-9","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"5 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Satauni study protocol was approved by the Ethics Committee of Satakunta Hospital District (2\u00a7\/7\/2008) and by the National Agency for Medicines of Finland (218\/2008) and registered to EudraCT (2008-0006795-30). Written informed consent was received from each participant before the study began.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants gave written consent that results could be published in scientific journals anonymously when individual participants cannot be identified, no data are published at an individual level, and the results are published at a group level.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"142"}}